HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Xiao Selected Research

Transplantation

1/2022Gut microbiota shapes social dominance through modulating HDAC2 in the medial prefrontal cortex.
12/2021Bone marrow mesenchymal stem cell therapy regulates gut microbiota to improve post-stroke neurological function recovery in rats.
1/2019Human Umbilical Cord Mesenchymal Stem Cells Attenuate Ocular Hypertension-Induced Retinal Neuroinflammation via Toll-Like Receptor 4 Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Xiao Research Topics

Disease

32Neoplasms (Cancer)
02/2021 - 05/2009
16Inflammation (Inflammations)
02/2022 - 01/2014
11Infections
06/2022 - 02/2010
10Hypertension (High Blood Pressure)
10/2021 - 10/2010
9Hypoxia (Hypoxemia)
01/2022 - 10/2012
7Fibrosis (Cirrhosis)
12/2022 - 04/2009
7Colitis
02/2022 - 01/2020
6Leukemia
01/2022 - 08/2009
5Mitochondrial Diseases (Mitochondrial Disease)
04/2022 - 10/2016
5Pain (Aches)
01/2022 - 07/2008
5Obesity
10/2021 - 06/2013
5Hepatocellular Carcinoma (Hepatoma)
01/2019 - 02/2010
4Chronic Renal Insufficiency
12/2022 - 01/2011
4Pancreatitis
06/2022 - 01/2019
4Diabetes Mellitus
10/2021 - 10/2010
4Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 01/2011
4Neuroinflammatory Diseases
10/2021 - 02/2016
4Myocardial Infarction
01/2021 - 01/2016
4Wounds and Injuries (Trauma)
09/2020 - 01/2017
4Carcinogenesis
06/2020 - 02/2010
4Reperfusion Injury
01/2018 - 01/2003
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2022 - 12/2012
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2022 - 01/2018
3Dysbiosis
01/2022 - 12/2020
3Hypersensitivity (Allergy)
01/2022 - 06/2020
3Stroke (Strokes)
01/2022 - 07/2021
3Cognitive Dysfunction
10/2021 - 02/2016
3Bacterial Infections (Bacterial Infection)
01/2021 - 11/2019
3Atherosclerosis
07/2020 - 01/2018
3Abdominal Aortic Aneurysm
07/2020 - 01/2020
3Osteoporosis
01/2020 - 04/2016
3Rupture
01/2020 - 02/2016
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2019 - 09/2016
3Atherosclerotic Plaque (Atheroma)
04/2019 - 02/2016
3Ischemia
01/2018 - 01/2003
3Pancreatic Neoplasms (Pancreatic Cancer)
06/2015 - 01/2014
2Alzheimer Disease (Alzheimer's Disease)
04/2022 - 10/2021
2Paralysis (Palsy)
04/2022 - 03/2019
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 08/2013
2Heart Failure
01/2022 - 10/2018
2Ganglion Cysts (Ganglion)
01/2022 - 01/2021
2Breast Neoplasms (Breast Cancer)
11/2021 - 10/2014
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021 - 01/2015
2Insulin Resistance
10/2021 - 09/2019
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2021 - 01/2021
2Neutropenia
10/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
12/2021 - 04/2016
10MicroRNAs (MicroRNA)IBA
01/2022 - 01/2014
10CholesterolIBA
03/2014 - 10/2010
9Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2011
9Pharmaceutical PreparationsIBA
01/2022 - 08/2009
9Biological ProductsIBA
01/2022 - 01/2014
6CytokinesIBA
02/2022 - 08/2013
6Glucose (Dextrose)FDA LinkGeneric
01/2022 - 04/2013
5Messenger RNA (mRNA)IBA
12/2021 - 01/2003
5Small Interfering RNA (siRNA)IBA
10/2018 - 01/2014
5CotinineIBA
01/2014 - 01/2013
4Circular RNAIBA
12/2022 - 01/2016
4AntioxidantsIBA
04/2022 - 04/2020
4Long Noncoding RNAIBA
01/2022 - 12/2017
4ElectrolytesIBA
12/2021 - 01/2015
4Apolipoproteins E (ApoE)IBA
07/2020 - 01/2017
4Angiotensin IIIBA
07/2020 - 01/2015
4NeuropeptidesIBA
06/2020 - 04/2016
4Therapeutic UsesIBA
01/2018 - 07/2008
4perfluorooctanoic acidIBA
03/2014 - 01/2011
3salvinIBA
04/2022 - 03/2019
3Dextran SulfateIBA
02/2022 - 06/2020
3Capsaicin (Zostrix)FDA Link
01/2022 - 09/2019
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 10/2016
3Adenosine Triphosphate (ATP)IBA
01/2022 - 02/2016
3trilaciclibIBA
01/2022 - 01/2021
3Caspase 3 (Caspase-3)IBA
10/2021 - 01/2016
3Polysaccharides (Glycans)IBA
06/2021 - 10/2016
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
09/2020 - 01/2017
3Hemostatics (Antihemorrhagics)IBA
04/2019 - 10/2010
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 02/2009
3perfluorooctaneIBA
03/2014 - 01/2011
3EnzymesIBA
02/2013 - 02/2010
2Streptozocin (Streptozotocin)FDA Link
08/2022 - 01/2021
2Carbapenems (Carbapenem Antibiotics)IBA
06/2022 - 03/2022
2Imatinib Mesylate (Gleevec)FDA Link
04/2022 - 01/2018
2Peptides (Polypeptides)IBA
04/2022 - 01/2016
2Tyrosine Kinase InhibitorsIBA
04/2022 - 01/2018
2PolyphenolsIBA
04/2022 - 02/2022
2LipidsIBA
03/2022 - 01/2017
2Inosine Triphosphate (ITP)IBA
01/2022 - 08/2013
2salicylhydroxamic acid (SHAM)IBA
12/2021 - 08/2021
2erythromycin propionate-N-acetylcysteinateIBA
11/2021 - 09/2020
2Analgesics (Analgesic Drugs)IBA
11/2021 - 04/2020
2von Willebrand FactorIBA
11/2021 - 09/2020
2Morphine (MS Contin)FDA LinkGeneric
11/2021 - 01/2016
2Cyclic AMP Receptors (Cyclic AMP Receptor)IBA
11/2021 - 09/2020
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2021 - 07/2021
2Sirtuin 1IBA
10/2021 - 01/2016
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2021 - 01/2019

Therapy/Procedure

15Therapeutics
01/2022 - 05/2005
11Drug Therapy (Chemotherapy)
01/2022 - 12/2012
3Transplantation
01/2022 - 01/2019
2Electroacupuncture
01/2022 - 01/2003